Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash
October 18, 2018 at 01:50 AM EDT
Swiss drugmaker Novartis raised its full-year sales outlook and announced on Thursday the $2.1 billion acquisition of U.S. biopharmaceutical company Endocyte.
